EMEA-000292-PIP01-08-M03
Key facts
Invented name |
Glybera
|
Active substance |
alipogene tiparvovec
|
Therapeutic area |
Cardiovascular diseases
|
Decision number |
P/0285/2016
|
PIP number |
EMEA-000292-PIP01-08-M03
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
Treatment of hyperchylomicronaemia
|
Route(s) of administration |
Intramuscular use
|
Contact for public enquiries |
uniQure biopharma B.V.
|
Decision type |
PM: decision on the application for modification of an agreed PIP
|